2,3-benzoxazines. IX. Synthesis and central nervous system depressant activity of some 3,6- and 3,7-disubstituted 1H-3,4-dihydro-2,3-benzoxazines.
D000698:Analgesia; D000818:Animals; D001241:Aspirin / Q000494:pharmacology; D001259:Ataxia / Q000139:chemically induced; D001463:Barbiturates / Q000494:pharmacology; D002490:Central Nervous System / Q000187:drug effects*; D002707:Chlordiazepoxide / Q000494:pharmacology; D002746:Chlorpromazine / Q000494:pharmacology; D005106:Exploratory Behavior / Q000187:drug effects; D008297:Male; D008620:Meprobamate / Q000494:pharmacology; D051379:Mice; D009020:Morphine / Q000494:pharmacology; D009043:Motor Activity / Q000187:drug effects; D009132:Muscles / Q000187:drug effects; D010078:Oxazines / Q000138:chemical synthesis* / Q000494:pharmacology* / Q000633:toxicity; D010672:Phenytoin / Q000494:pharmacology; D011728:Pyridones / Q000494:pharmacology*; D051381:Rats; D012018:Reflex / Q000187:drug effects; D012640:Seizures / Q000188:drug therapy
D001463:Barbiturates; D010078:Oxazines; D011728:Pyridones; D010672:Phenytoin; D002707:Chlordiazepoxide; D009020:Morphine; D008620:Meprobamate; D001241:Aspirin; D002746:Chlorpromazine